Literature DB >> 24829174

Disseminated intravascular coagulation as clinical manifestation of colorectal cancer: a case report and review of the literature.

C C van Bunderen1, V A de Weger, A Griffioen-Keijzer.   

Abstract

We describe the case of a 65-year-old woman, known with ulcerative colitis, who presented with progressive headaches, haematomas and rectal bleeding which turned out to be the initial manifestation of disseminated intravascular coagulation (DIC) associated with colorectal cancer. The presentation posed as a general medicine case but turned out to be a rare oncological complication. The patient revealed possible carcinocythaemia and bone marrow infiltration with signet ring-like cells, as indicators of advanced adenocarcinoma. Treatment of the underlying disease resolved the DIC and contributed to prolonged survival. Subsequently, we reviewed the English literature since 1990 on similar cases and demonstrated that this association is extremely rare and is associated with a poor prognosis. Prompt recognition and treatment of the underlying disease is confirmed to be of utmost importance to prolong (progression-free) survival.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24829174

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  2 in total

1.  Treatment of Rectal Cancer-Induced Disseminated Carcinomatosis of the Bone Marrow with FOLFOX plus Cetuximab and Panitumumab.

Authors:  Takehito Ehara; Masato Kitazawa; Nao Hondo; Shugo Takahata; Yuta Yamamoto; Makoto Koyama; Motohiro Okumura; Satoshi Nakamura; Shigeo Tokumaru; Futoshi Muranaka; Yusuke Miyagawa; Yuji Soejima
Journal:  Case Rep Oncol       Date:  2020-02-17

2.  Disseminated carcinomatosis of the bone marrow with disseminated intravascular coagulation as the first symptom of recurrent rectal cancer successfully treated with chemotherapy: A case report and review of the literature.

Authors:  Hiroshi Takeyama; Tsutomu Sakiyama; Tomoko Wakasa; Kotaro Kitani; Keisuke Inoue; Hiroaki Kato; Shinya Ueda; Masanori Tsujie; Yoshinori Fujiwara; Masao Yukawa; Yoshio Ohta; Masatoshi Inoue
Journal:  Oncol Lett       Date:  2017-04-04       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.